Key terms

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest LLY news

Yesterday 2:31am ET Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Eli Lilly & Co (LLY) May 01 10:04am ET Eli Lilly price target raised to $892 from $850 at Truist May 01 8:55am ET Eli Lilly price target raised to $1,001 from $900 at BMO Capital May 01 7:29am ET Eli Lilly price target raised to $885 from $815 at Cantor Fitzgerald May 01 7:15am ET Truist Financial Keeps Their Buy Rating on Eli Lilly & Co (LLY) May 01 6:51am ET Galderma Seizes Ozempic Face Opportunity May 01 6:50am ET Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Axonics Modulation Technologies (AXNX) and Eli Lilly & Co (LLY) May 01 6:42am ET Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Exelixis (EXEL) and Zynex (ZYXI) May 01 6:37am ET Eli Lilly price target raised to $875 from $825 at Wells Fargo May 01 6:14am ET Wall Street Analysts Are Bullish on Top Healthcare Picks May 01 5:12am ET Eli Lilly price target raised to $913 from $810 at Barclays Apr 30 10:13am ET FTC expands patent listing challenges for drugs Apr 30 9:59am ET LLY Earnings: Eli Lilly Gains on Strong Q1 Earnings Beat Apr 30 9:55am ET Early notable gainers among liquid option names on April 30th Apr 30 9:40am ET Unusually active option classes on open April 30th Apr 30 9:32am ET Analysts’ Top Healthcare Picks: Qiagen (QGEN), Eli Lilly & Co (LLY) Apr 30 9:30am ET Bank of America Securities Keeps Their Buy Rating on Eli Lilly & Co (LLY) Apr 30 7:01am ET Eli Lilly raises FY24 adjusted EPS view to $13.50-$14.00 from $12.20-$12.70 Apr 30 6:59am ET Eli Lilly reports Q1 EPS $2.58, consensus $2.46 Apr 29 8:25pm ET Notable companies reporting before tomorrow’s open Apr 29 1:45pm ET Notable companies reporting before tomorrow’s open Apr 24 11:24pm ET LLY vs. JNJ: Which Big Pharma Stock Is Better? Apr 22 1:04pm ET Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans Apr 22 3:50am ET Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Eli Lilly & Co (LLY) Apr 19 6:17am ET Influencers are talking up weight loss drugs, but omit side effects, WSJ says Apr 18 9:30am ET Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), TG Therapeutics (TGTX) Apr 18 8:24am ET UBS remains bullish on Inspire Medical after Lilly’s OSA results Apr 18 8:20am ET Analysts Conflicted on These Healthcare Names: Intra-Cellular Therapies (ITCI), Eli Lilly & Co (LLY) and Sanofi (OtherSNYNF) Apr 18 7:30am ET Analysts’ Top Healthcare Picks: Inspire Medical Systems (INSP), Eli Lilly & Co (LLY) Apr 18 7:20am ET Analysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB) and Eli Lilly & Co (LLY) Apr 18 6:00am ET Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), US Physical Therapy (USPH)

No recent press releases are available for LLY

LLY Financials

1-year income & revenue

Key terms

LLY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

LLY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms